Item 9 Labs Corp (INLB)
0.0001
0.00 (0.00%)
USD |
OTCM |
May 17, 15:34
Item 9 Labs Total Assets (Quarterly): 112.02M for June 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
June 30, 2023 | 112.02M |
March 31, 2023 | 114.13M |
December 31, 2022 | 114.67M |
September 30, 2022 | 110.76M |
June 30, 2022 | 120.53M |
March 31, 2022 | 120.87M |
December 31, 2021 | 117.02M |
September 30, 2021 | 116.81M |
June 30, 2021 | 149.92M |
March 31, 2021 | 153.13M |
December 31, 2020 | 25.98M |
September 30, 2020 | 20.66M |
June 30, 2020 | 22.31M |
March 31, 2020 | 21.49M |
December 31, 2019 | 14.64M |
September 30, 2019 | 14.47M |
June 30, 2019 | 19.38M |
September 30, 2018 | 3.513M |
March 31, 2018 | 3.515M |
December 31, 2017 | 0.1145M |
September 30, 2017 | 1.021M |
June 30, 2017 | 0.1052M |
March 31, 2017 | 0.07M |
Date | Value |
---|---|
December 31, 2016 | 0.0529M |
September 30, 2016 | 0.0892M |
June 30, 2016 | 0.0473M |
March 31, 2016 | 0.1025M |
December 31, 2015 | 0.0768M |
September 30, 2015 | 0.1127M |
June 30, 2015 | 0.4208M |
March 31, 2015 | 0.4706M |
December 31, 2014 | 0.6301M |
September 30, 2014 | 0.5087M |
June 30, 2014 | 0.4952M |
March 31, 2014 | 0.5091M |
December 31, 2013 | 0.5383M |
September 30, 2013 | 0.4425M |
June 30, 2013 | 0.5952M |
March 31, 2013 | 0.7649M |
December 31, 2012 | 0.6365M |
June 30, 2012 | 0.4512M |
March 31, 2012 | 24.13M |
December 31, 2011 | 0.00 |
September 30, 2011 | 0.0203M |
December 31, 2010 | 0.0203M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
14.47M
Minimum
Sep 2019
153.13M
Maximum
Mar 2021
80.52M
Average
112.02M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
Humanigen Inc | 5.116M |
Cannabis Global Inc | 14.91M |
Cantabio Pharmaceuticals Inc | 0.3259M |
Affymax Inc | -- |
Statera BioPharma Inc | 12.75M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 59.37M |
Shareholders Equity (Quarterly) | 52.65M |
Debt to Equity Ratio | 0.6439 |
Current Ratio | 0.0569 |
Net Debt Paydown Yield | -30.33% |